Skip to main content
Scholars@Duke
Menu
About
Schools / Institutes
Browse
K36 Therapeutics: Ph1 KTX-1001 Oral, FIC, MMSET Cat Inhib in Pts w/ RRMM
Clinical Trial Grant
Duke Scholars
Principal Investigator
Cristina Gasparetto
Medicine, Hematologic Malignancies and Cellular Therapy
Awarded By
K36 Therapeutics
Start Date
April 11, 2023
End Date
March 31, 2028
Awarded By
K36 Therapeutics
Start Date
April 11, 2023
End Date
March 31, 2028
